4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-21-005226
President sold 15,000 shares at an average $66.84 ($1,002,547)
- President acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| RUBINSTEIN JULIE President | 2021-01-22 | Option exercise | +15,000 | $6.32 | $94,800 | 15,000 | D |
| RUBINSTEIN JULIE President | 2021-01-22 | Sale | −5,524 | $66.23 | $365,855 | 9,476 | D |
| RUBINSTEIN JULIE President | 2021-01-22 | Sale | −9,476 | $67.19 | $636,692 | 0 | D |
| Derivatives | |||||||
| RUBINSTEIN JULIE President | 2021-01-22 | Option exercise · Stock Option (Right to Buy) | −15,000 | 170,000 | D | ||
| Open-market sales · 15,000 sh · avg $66.84 · $1,002,547 | |||||||
Loading xslF345X03/doc4.xml…